Showing results (201-210 of 297) with videos related to

Sort By:
Pageof 30
British Journal of Haematology|February 22, 2021
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemiaSanam Loghavi, Courtney D DiNardo, Ken Furudate, et al.
Cancer|June 25, 2021
A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemiaKapil Saxena, Shelley M Herbrich, Naveen Pemmaraju, et al.
Blood Cancer Discovery|April 14, 2026
Integrated analysis of genomics, molecular responses and outcomes of CBF-AML with FLAG based therapy on a phase 2 trialJayastu Senapati, Hagop M Kantarjian, Edward Ayoub, et al.
British Journal of Haematology|May 23, 2019
Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapyHaitham Khogeer, Haitham Rahman, Nitin Jain, et al.
Blood Neoplasia|September 22, 2025
Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1Courtney D DiNardo, Wei-Ying Jen, Guillermo Montalban-Bravo, et al.
American Journal of Hematology|May 22, 2025
A Phase 2 Trial of CPX-351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaTapan M Kadia, Wei-Ying Jen, Alex Bataller, et al.
Leukemia|May 9, 2025
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangementsAlex Bataller, Hannah E Goulart, Ghayas C Issa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1Andrés E Quesada, Guillermo Montalban-Bravo, Rajyalakshmi Luthra, et al.
Virchows Archiv : an International Journal of Pathology|March 2, 2023
Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variantSiba El Hussein, L Jeffrey Medeiros, Stephen K Gruschkus, et al.
Cell Reports. Medicine|May 23, 2024
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, et al.
Pageof 30